Peer Review reports
From: APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
Original Submission | ||
---|---|---|
10 Oct 2023 | Submitted | Original manuscript |
25 Nov 2023 | Reviewed | Reviewer Report - Nicholas Adzibolosu |
27 Nov 2023 | Reviewed | Reviewer Report |
8 Jan 2024 | Author responded | Author comments - Dongmei Zhou |
25 Jan 2024 | Author responded | Author comments - Dongmei Zhou |
Resubmission - Version 2 | ||
8 Jan 2024 | Submitted | Manuscript version 2 |
1 Feb 2024 | Author responded | Author comments - Dongmei Zhou |
Resubmission - Version 3 | ||
1 Feb 2024 | Submitted | Manuscript version 3 |
2 Feb 2024 | Author responded | Author comments - Dongmei Zhou |
Resubmission - Version 4 | ||
2 Feb 2024 | Submitted | Manuscript version 4 |
22 Feb 2024 | Author responded | Author comments - Dongmei Zhou |
Resubmission - Version 5 | ||
22 Feb 2024 | Submitted | Manuscript version 5 |
2 Mar 2024 | Author responded | Author comments - Dongmei Zhou |
Resubmission - Version 6 | ||
2 Mar 2024 | Submitted | Manuscript version 6 |
Publishing | ||
11 Mar 2024 | Editorially accepted | |
21 Mar 2024 | Article published | 10.1186/s12885-024-12105-z |
You can find further information about peer review here.